Evidence map›Paper›PMID 33055514›Full record

ArticleOptometry and vision science : official publication of the American Academy of Optometry2020

2017 Charles F. Prentice Award Lecture: Peripheral Prisms for Visual Field Expansion: A Translational Journey.

Eli Peli

Abstract readLecture
In one paragraph

Article in Optometry and vision science : official publication of the American Academy of Optometry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Development of Virtual Reality Walking Collision Detection Test on Head-mounted display.Proceedings of SPIE--the International Society for Optical Engineering
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Eli PeliSchepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Patricia Ann D'Amore · 1985 to 2026
$25.5M
Mass Eye and Ear-Vision Clinical Scientist Development ProgramK12EY016335 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Reza Dana · 2004 to 2026
$12.3M
VISUAL FIELD EXPANSION THROUGH INNOVATIVE MULTIPLEXING PRISM DESIGNR01EY023385 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI PELI, ELI · 2013 to 2024
$7.2M
ENGINEERING APPROACHES TO LOW VISION REHABILITATIONR24EY012890 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI PELI, ELI · 2000 to 2005
$7.2M
ENGINEERING APPROACHES TO LOW VISION REHABILITATIONR01EY012890 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI PELI, ELI · 2006 to 2010
$7.0M
Scanning and Detection at IntersectionsR01EY025677 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Alexandra Rae Bowers · 2015 to 2026
$6.9M
Driving Simulator for Vision ResearchS10RR028122 · NCRR · SCHEPENS EYE RESEARCH INSTITUTE · PI PELI, ELI · 2010 to 2010
$333k
NCRR NIH HHS S10 RR028122NEI NIH HHS K12 EY016335NEI NIH HHS P30 EY003790NEI NIH HHS R01 EY012890NEI NIH HHS R01 EY023385NEI NIH HHS R01 EY025677NEI NIH HHS R24 EY012890
6 · The paper itself

Abstract

On the occasion of being awarded the Prentice Medal, I was asked to summarize my translational journey. Here I describe the process of becoming a low-vision rehabilitation clinician and researcher, frustrated by the unavailability of effective treatments for some conditions. This led to decades of working to understand patients' needs and the complexities and subtleties of their visual systems and conditions. It was followed by many iterations of developing vision aids and the techniques needed to objectively evaluate their benefit. I specifically address one path: the invention and development of peripheral prisms to expand the visual fields of patients with homonymous hemianopia, leading to our latest multiperiscopic prism (mirror-based design) with its clear 45° field-of-view image shift.

Indexed as

EyeglassesAwards and PrizesHemianopsiaHumansTreatment OutcomeVision, LowVisual Fields

Identifiers

PMID33055514
PMCPMC7606588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.